HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 856278Generated: October 31, 2026
Sodium Acetate → 2-(4-Tert-butoxycarbonylpiperazin-1-yl)methyl-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole
https://huagongshe.com/reaction/856278
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Acetate | HCID 517045 | — |
| Reactant | Tert-butyl 4-(2-methyloxiran-2-ylmethyl)-piperazine-1-carboxylate | HCID 23081489 | — |
| Reactant | HCID 178526855 | HCID 178526855 | — |
| Solvent | 1-Propanol | HCID 1031 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | 2-(4-Tert-butoxycarbonylpiperazin-1-yl)methyl-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole | HCID 23081080 | 23.3% |
Reaction Steps
2-Chloro-4-nitro-1H-imidazole (3.19 g, 21.6 mmol) and tert-butyl 4-(2-methyloxiran-2-ylmethyl)-piperazine-1-carboxylate (5.53 g, 21.6 mmol) and sodium acetate (1.95 g, 23.8 mmol) were dissolved in 1-propanol (50 ml) followed by stirring under reflux for 48 hours. The reaction mixture was diluted with methylene chloride. The solution was washed with water and a saturated saline solution, dried over sodium sulfate and then filtered. The filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (methylene chloride/methanol=100/1) and treated with methylene chloride-diisopropyl ether to afford 2-(4-tert-butoxycarbonylpiperazin-1-yl)methyl-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole (1.85 g, yield 23%) as a white powder.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07262212B2 |
|---|
| Source dataset | uspto-grants-2007_08 |
|---|
| ORD ID | ord-eca063392a804a40b293e7142b2b0389 |
|---|
| Source note | uspto-grants-2007_08 |
|---|